Oct 10, 2017 - 348. ArXiv:1409.1638 [hep-ph]. Boguslavski, S. Schlichting, R. Soc., 50 (2007), p.

KSU - Electronic Mosshaf project 'Ayat', you are now browsing the desktop interface, the project also provides a, a, an, an, a and a Special thanks to (source of Quran images files), (source of Quran text and translations), (source of Tafasir (explanations)) and (source of recitations audio files). Disclaimer: No translation of Quran can be a hundred percent accurate, nor it can be used as a replacement of the Quran text. We got Quran translations from Tanzil.net website, we cannot guarantee their authenticity and/or accuracy. Please use them at your own discretion.

Family tree maker 2006 torrent. Results APS nephropathy existed in 39.5% of patients with aPL, compared with only 4.3% of patients without aPL. APS nephropathy was associated with both lupus anticoagulant and anticardiolipin antibodies. Calculator.

Among aPL‐positive SLE patients, APS nephropathy was found in two‐thirds of those with APS and in one‐third of those without APS. A strong association between APS nephropathy and the presence of arterial thrombosis and livedo reticularis was noted. Patients with APS nephropathy had a higher frequency of hypertension and elevated serum creatinine levels at the time of kidney biopsy but did not have a higher frequency of renal insufficiency, end‐stage renal disease, or death at the end of followup.

Serial kidney biopsy specimens were available from 11 patients and showed progression of APS nephropathy lesions. During followup, manifestations of APS (especially arterial thromboses) developed more frequently in the SLE/non‐APS patients with APS nephropathy than in those without APS nephropathy. Conclusion Among patients with SLE, APS nephropathy occurs almost exclusively in those with aPL, suggesting an important role of aPL in the pathogenesis of APS nephropathy. Patients with APS nephropathy develop hypertension, raised serum creatinine levels, and progression of histologic lesions, all of which are associated with a poor renal outcome. Manifestations of APS also tend to develop in these patients.

APS nephropathy should be included in the APS classification criteria, and the use of appropriate anticoagulant therapy should be tested. The antiphospholipid syndrome (APS) is a multisystem disease characterized by arterial and venous thromboses, pregnancy morbidity, and the presence of antiphospholipid antibodies (aPL), namely anticardiolipin antibodies (aCL) and lupus anticoagulant (LAC) (, ). APS is classified as primary or classified as secondary when it occurs in the context of other underlying disorders, mainly systemic lupus erythematosus (SLE) ( ).